India-Brazil Trade is set for a major expansion as both countries target USD 30 billion in bilateral trade by 2030. The India-Brazil Trade partnership is also gaining momentum through wider market access for Indian pharmaceutical products.
India is seeing an H1N1 flu surge, and flu vaccine demand has jumped sharply as influenza cases rise across the country. Vaccine sales are now nearly three times higher than last year. The demand has also more than doubled compared with July.
In this conversation with Thiruamuthan, Assistant Editor at India Pharma Outlook, Akhil Ravi, CEO, Aurigene Pharmaceutical, shares his perspective on building a scalable CDMO business, earning long-term customer trust, developing capabilities in comp
AstraZeneca has scored with Tezspire in a third inflammatory disease in a Phase 3 trial. Developed with Amgen, Tezspire met both co-primary endpoints in the late-stage trial for eosinophilic esophagitis
Dr Reddy’s Laboratories has secured a key approval for its arthritis treatment portfolio in India. The company received marketing approval for its abatacept biosimilar from the Central Drugs Standard Control Organisation (CDSCO).
India’s new Medical Device Rule could increase compliance costs for manufacturers. The rule requires makers to disclose details of outsourced sterilization facilities on device labels. The medical device rule is aimed at improving traceability...
Calcium Gluconate has become the latest addition to Glenmark Pharmaceuticals' U.S. injectable portfolio, this move supports its strategy to build a differentiated, sustainable U.S. injectables business focused on institutional demand
Mankind Pharma has signed an in-licensing deal with China’s Chongqing Chenan Biopharmaceutical to commercialise two insulin analogues in India and strengthen its diabetes portfolio.
Ophthalmology is becoming a stronger specialty-care focus for Lupin as the company expands its European eye-care business through VISUfarma
Glenmark’s latest USFDA approval covers Fluticasone Propionate Nasal Spray. The FDA has determined the product to be bioequivalent and therapeutically equivalent to Flonase Nasal Spray
.jpg)
, CDSCO.jpg)
